Cargando…

P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Iula, R, Trastulli, F, Della Pepa, R, D’Ambrosio, A, Romano, M, Leone, A, Gaeta, G, Palmieri, S, Rocco, S, Pane, F, Ferrara, F, Catalano, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011767/
http://dx.doi.org/10.1097/01.HS9.0000829652.00958.65
_version_ 1784687690722050048
author Iula, R
Trastulli, F
Della Pepa, R
D’Ambrosio, A
Romano, M
Leone, A
Gaeta, G
Palmieri, S
Rocco, S
Pane, F
Ferrara, F
Catalano, L
author_facet Iula, R
Trastulli, F
Della Pepa, R
D’Ambrosio, A
Romano, M
Leone, A
Gaeta, G
Palmieri, S
Rocco, S
Pane, F
Ferrara, F
Catalano, L
author_sort Iula, R
collection PubMed
description
format Online
Article
Text
id pubmed-9011767
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-90117672022-04-18 P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA Iula, R Trastulli, F Della Pepa, R D’Ambrosio, A Romano, M Leone, A Gaeta, G Palmieri, S Rocco, S Pane, F Ferrara, F Catalano, L Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9011767/ http://dx.doi.org/10.1097/01.HS9.0000829652.00958.65 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Poster
Iula, R
Trastulli, F
Della Pepa, R
D’Ambrosio, A
Romano, M
Leone, A
Gaeta, G
Palmieri, S
Rocco, S
Pane, F
Ferrara, F
Catalano, L
P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
title P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_fullStr P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_full_unstemmed P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_short P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
title_sort p20: polycentric “real life” study of belantamab mafodotin for relapsed/refractory multiple myeloma
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011767/
http://dx.doi.org/10.1097/01.HS9.0000829652.00958.65
work_keys_str_mv AT iular p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT trastullif p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT dellapepar p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT dambrosioa p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT romanom p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT leonea p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT gaetag p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT palmieris p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT roccos p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT panef p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT ferraraf p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma
AT catalanol p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma